Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Pharmaceuticals ETF

105.42
+0.26000.25%
Pre-market: 105.500.0800+0.08%04:00 EDT
Volume:144.16K
Turnover:15.16M
Market Cap:1.69B
PE:9.82
High:105.87
Open:105.87
Low:104.06
Close:105.16
52wk High:108.66
52wk Low:69.02
Shares:16.00M
Float Shares:16.00M
Volume Ratio:0.49
T/O Rate:0.90%
Dividend:1.47
Dividend Rate:1.39%
EPS(TTM):10.74
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Wells Fargo Adjusts Price Target on Merck & Co. to $170 From $150, Keeps Overweight Rating

MT Newswires Live
·
1 hour ago

Market Chatter: Bristol Myers Squibb Paused Zola-Cel Trials Over Safety Concerns

MT Newswires Live
·
1 hour ago

Dow Jones Top Company Headlines at 11 PM ET: the 'Deeply Nerdy' Founders Behind Nvidia's $13 Billion Bet on Hugging Face | Musk's ...

Dow Jones
·
7 hours ago

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
13 hours ago

Eli Lilly Stock (LLY) Gets a Bullish Note from JPMorgan Chase

TIPRANKS
·
15 hours ago

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
16 hours ago

Eisai’s Lenvima Combo Trial in Liver Cancer Ends With Mixed but Market-Relevant Results

TIPRANKS
·
18 hours ago

Summit Therapeutics Says it is Beating Merck with Its Cancer Drug

Dow Jones
·
18 hours ago

Aspen Sees Mounjaro Africa Sales Above $124 Million in 2027

Reuters
·
Yesterday

Eikon Therapeutics Names Ching-Pin Chang as Chief Scientific Officer

Reuters
·
Yesterday

Superluminal Medicines: Financing Led by Bvf Partners; Alongside Existing Investors Nvidia, Eli Lilly & Co, Cooley, and Gaingels, Among Others

THOMSON REUTERS
·
Yesterday

Rothschild & Co Redburn Adjusts PT on Eli Lilly and Co. to $930 From $915, Keeps Neutral Rating

MT Newswires Live
·
Yesterday

Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services

Dow Jones
·
Yesterday

Jefferies Reaffirms Their Hold Rating on Merck KGaA (0O14)

TIPRANKS
·
Yesterday

Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Yesterday

Bristol Myers Squibb Co. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Yesterday

Johnson & Johnson to Present at Deutsche Bank 2026 Healthcare Summit

Reuters
·
Yesterday

Option traders moderately bearish in Eli Lilly with shareslittle changed

TIPRANKS
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Johnson & Johnson's Drug Pipeline Supports Growth Outlook, UBS Securities Says

MT Newswires Live
·
Sep 02